Document is current

Chapter History

First Online: 21 October 2023

Institutional Review Board Statement

: Not applicable.

: Not applicable.

: Not applicable.

: The authors declare no conflict of interest.

: S.T., P.S., L.C.R, C.G.-R. and J. F.-C. revised the literature and discussed reported findings and conceived the focus of the review. S.T., P.S. and L.C.R. conceived the figs. S.T., P.S., L.C.R, C.G.-R. and J.F.-C. wrote the manuscript. All authors have read and agreed to the published version of the manuscript.

: We acknowledge the support from grants PID2019-111669RB-100 and PID2020-115055RB-I00 from Plan Nacional de I + D funded by the Agencia Estatal de Investigación (AEI) and the Fondo Europeo de Desarrollo Regional (FEDER) and from the CIBEREHD; the center grant P50AA011999 Southern California Research Center for ALPD and Cirrhosis funded by NIAAA/NIH; as well as support from AGAUR of the Generalitat de Catalunya SGR-2017- 1112, European Cooperation in Science & Technology (COST) ACTION CA17112 Prospective European Drug- In-duced Liver Injury Network, and the Red Nacional 2018–102,799-T de Enfermedades Metabólicas y Cáncer and the Project 201,916/31 Contribution of mitochondrial oxysterol and bile acid metabolism to liver carcinogenesis 2019 by Fundació Marató TV3.